Innovations in treating and therapeutics for tropical diseases are transforming global health efforts, offering new hope for vulnerable populations disproportionately affected by these conditions. These innovations include mRNA vaccines for the Zika virus, CRISPR-based gene editing for vector control and pathogen suppression, nanotechnology-enabled drug delivery systems like liposomal amphotericin B for leishmaniasis, AI-driven drug discovery platforms accelerating the identification of novel therapeutics, wearable health devices for real-time monitoring of treatment outcomes, 3D-printed personalized medicines for neglected tropical diseases, advanced diagnostic tools like multiplex PCR for rapid pathogen identification, drone technology for delivering medical supplies to remote areas, mobile health applications for improving treatment adherence, and telemedicine platforms for remote disease management in resource-limited settings. This chapter focuses on how advancements such as digital health technologies, artificial intelligence in drug discovery, nanotechnology, and innovative service delivery models are reshaping the management and control of tropical diseases. These breakthroughs improve drug delivery, enhance bioavailability, reduce drug resistance, and accelerate the development of affordable and effective treatments. Drug repurposing has emerged as a cost-effective strategy, enabling the rapid deployment of existing medications for neglected diseases. At the same time, nanotechnology provides innovative solutions through controlled-release formulations and combination therapies. Integrating personalized medicine and sustainable drug development practices further underscores the commitment to health equity and ecological responsibility. Localized therapeutics production reduces import dependency, ensuring timely access to essential medicines. Meanwhile, global collaborations in research and technology sharing drive the development of novel therapies and foster resilience against challenges such as emerging tropical diseases and drug resistance. Achieving sustainable development in tropical disease therapeutics requires addressing mental health implications, fostering cross-sector partnerships, and prioritizing equitable access to innovations. As the global health landscape evolves, these advancements will be vital in eradicating tropical diseases, improving health outcomes, and enhancing the quality of life for affected populations.